Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model

D. C. Gritz, P. J. McDonnell, T. Y. Lee, D. Tang-Liu, B. B. Hubbard, A. Gwon

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ofloxacin, a new quinolone antibiotic with a broad spectrum of activity, is very effective against Pseudomonas aeruginosa in vitro. Its effectiveness was studied in a rabbit model of tobramycin-sensitive P. aeruginosa. Treatment groups received either vehicle, tobramycin 0.3%, or ofloxacin 0.3%. Twelve hours of treatment decreased the bacterial counts from a mean of 2.2 ± 0.7 x 106 colony forming units (cfu) per cornea in the vehicle group to means of 513 ± 670 and 435 ± 524 cfu in the tobramycin and ofloxacin groups, respectively. This decrease in bacterial counts was statistically significant (p = 0.001 for tobramycin and ofloxacin each compared with control, p = 0.86 for tobramycin compared with ofloxacin). After seven days, all antibiotic-treated corneas were sterile and the epithelial defects healed at comparable rates. Aqueous humor drug levels were higher in infected eyes without an intact epithelium (p = 0.02); in eyes with intact epithelium, concentrations of ofloxacin were higher than were those of tobramycin (p = 0.002). In this animal model, ofloxacin proved to be an effective antibiotic with no evidence of toxicity.

Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalCornea
Volume11
Issue number2
StatePublished - 1992
Externally publishedYes

Fingerprint

Ofloxacin
Keratitis
Tobramycin
Pseudomonas
Rabbits
Bacterial Load
Anti-Bacterial Agents
Cornea
Pseudomonas aeruginosa
Stem Cells
Epithelium
Aqueous Humor
Quinolones
Animal Models
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Gritz, D. C., McDonnell, P. J., Lee, T. Y., Tang-Liu, D., Hubbard, B. B., & Gwon, A. (1992). Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Cornea, 11(2), 143-147.

Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. / Gritz, D. C.; McDonnell, P. J.; Lee, T. Y.; Tang-Liu, D.; Hubbard, B. B.; Gwon, A.

In: Cornea, Vol. 11, No. 2, 1992, p. 143-147.

Research output: Contribution to journalArticle

Gritz, DC, McDonnell, PJ, Lee, TY, Tang-Liu, D, Hubbard, BB & Gwon, A 1992, 'Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model', Cornea, vol. 11, no. 2, pp. 143-147.
Gritz DC, McDonnell PJ, Lee TY, Tang-Liu D, Hubbard BB, Gwon A. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Cornea. 1992;11(2):143-147.
Gritz, D. C. ; McDonnell, P. J. ; Lee, T. Y. ; Tang-Liu, D. ; Hubbard, B. B. ; Gwon, A. / Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. In: Cornea. 1992 ; Vol. 11, No. 2. pp. 143-147.
@article{a750385a23184aa5aa7393976b232917,
title = "Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model",
abstract = "Ofloxacin, a new quinolone antibiotic with a broad spectrum of activity, is very effective against Pseudomonas aeruginosa in vitro. Its effectiveness was studied in a rabbit model of tobramycin-sensitive P. aeruginosa. Treatment groups received either vehicle, tobramycin 0.3{\%}, or ofloxacin 0.3{\%}. Twelve hours of treatment decreased the bacterial counts from a mean of 2.2 ± 0.7 x 106 colony forming units (cfu) per cornea in the vehicle group to means of 513 ± 670 and 435 ± 524 cfu in the tobramycin and ofloxacin groups, respectively. This decrease in bacterial counts was statistically significant (p = 0.001 for tobramycin and ofloxacin each compared with control, p = 0.86 for tobramycin compared with ofloxacin). After seven days, all antibiotic-treated corneas were sterile and the epithelial defects healed at comparable rates. Aqueous humor drug levels were higher in infected eyes without an intact epithelium (p = 0.02); in eyes with intact epithelium, concentrations of ofloxacin were higher than were those of tobramycin (p = 0.002). In this animal model, ofloxacin proved to be an effective antibiotic with no evidence of toxicity.",
author = "Gritz, {D. C.} and McDonnell, {P. J.} and Lee, {T. Y.} and D. Tang-Liu and Hubbard, {B. B.} and A. Gwon",
year = "1992",
language = "English (US)",
volume = "11",
pages = "143--147",
journal = "Cornea",
issn = "0277-3740",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model

AU - Gritz, D. C.

AU - McDonnell, P. J.

AU - Lee, T. Y.

AU - Tang-Liu, D.

AU - Hubbard, B. B.

AU - Gwon, A.

PY - 1992

Y1 - 1992

N2 - Ofloxacin, a new quinolone antibiotic with a broad spectrum of activity, is very effective against Pseudomonas aeruginosa in vitro. Its effectiveness was studied in a rabbit model of tobramycin-sensitive P. aeruginosa. Treatment groups received either vehicle, tobramycin 0.3%, or ofloxacin 0.3%. Twelve hours of treatment decreased the bacterial counts from a mean of 2.2 ± 0.7 x 106 colony forming units (cfu) per cornea in the vehicle group to means of 513 ± 670 and 435 ± 524 cfu in the tobramycin and ofloxacin groups, respectively. This decrease in bacterial counts was statistically significant (p = 0.001 for tobramycin and ofloxacin each compared with control, p = 0.86 for tobramycin compared with ofloxacin). After seven days, all antibiotic-treated corneas were sterile and the epithelial defects healed at comparable rates. Aqueous humor drug levels were higher in infected eyes without an intact epithelium (p = 0.02); in eyes with intact epithelium, concentrations of ofloxacin were higher than were those of tobramycin (p = 0.002). In this animal model, ofloxacin proved to be an effective antibiotic with no evidence of toxicity.

AB - Ofloxacin, a new quinolone antibiotic with a broad spectrum of activity, is very effective against Pseudomonas aeruginosa in vitro. Its effectiveness was studied in a rabbit model of tobramycin-sensitive P. aeruginosa. Treatment groups received either vehicle, tobramycin 0.3%, or ofloxacin 0.3%. Twelve hours of treatment decreased the bacterial counts from a mean of 2.2 ± 0.7 x 106 colony forming units (cfu) per cornea in the vehicle group to means of 513 ± 670 and 435 ± 524 cfu in the tobramycin and ofloxacin groups, respectively. This decrease in bacterial counts was statistically significant (p = 0.001 for tobramycin and ofloxacin each compared with control, p = 0.86 for tobramycin compared with ofloxacin). After seven days, all antibiotic-treated corneas were sterile and the epithelial defects healed at comparable rates. Aqueous humor drug levels were higher in infected eyes without an intact epithelium (p = 0.02); in eyes with intact epithelium, concentrations of ofloxacin were higher than were those of tobramycin (p = 0.002). In this animal model, ofloxacin proved to be an effective antibiotic with no evidence of toxicity.

UR - http://www.scopus.com/inward/record.url?scp=0026580890&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026580890&partnerID=8YFLogxK

M3 - Article

C2 - 1582217

AN - SCOPUS:0026580890

VL - 11

SP - 143

EP - 147

JO - Cornea

JF - Cornea

SN - 0277-3740

IS - 2

ER -